About Joel Tune
Form D filings for ResQ Pharma from 2022 to 2024 list Joel Tune as independent director.
Joel Tune first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Joel Tune in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joel Tune works with at each company, as listed on that company's latest Form D.
ResQ Pharma, Inc. · Form D, Dec 31, 2024
AS
August Schupp
Director, CAO and General Counsel
DK
Dominic O'Keefe
Director and COO
GW
Guy Weinberg
Director, President and Secretary